Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/6/2018
SIETES contiene 92381 citas

 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Gargiulo G, Windecker S, da Costa BR, Feres F, Hong M-K, Gilard M, Kim H-S, Colombo A, Bhatt DL, Kim B-K, Morice M-C, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ 2016;355:i5483. [Ref.ID 100878]
2.Tiene citas relacionadas Cita con resumen
Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F, Abizaid A, Hong M-K, Kim B-K, Jang Y, Kim H-S, Park KW, Genereux P, Bhatt DL, Orlandi C, De Servi S, Petrou M, Rapezzi C, Stone GW. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. Lancet 2015;385:2371-82. [Ref.ID 99292]
3.Tiene citas relacionadas Cita con resumen
Koo B-K, Kim Y-S, Park KW, Yang HM, Kwon D-A, Chung JW, Hahn JY, Lee H-Y, Park JS, Kang H-J, Cho YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Kim H-S. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. Lancet 2007;370:567-74. [Ref.ID 80808]
Suh JW, Koo B-K, Zhang SY, Park KW, Cho JY, Jang I-J, Lee D-S, Sohn DW, Lee M-M, Kim H-S. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. Can Med Assoc J 2006;174:1715-22. [Ref.ID 77064]
Seleccionar todas
 1 a 5 de 5